ADAM inhibitors (Incyte)

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug NameADAM inhibitors (Incyte)
Drug Alias NameHER-2 sheddase inhibitors (Incyte)A disintegrin and metalloprotease inhibitors (Incyte)IAI-102INCB-3619INCB-3531 +[6] 
ClassificationSmall molecules
Mechanisms of ActionDisintegrin and metalloproteinase domain-containing protein 10 inhibitorsApoptosis stimulants
TargetsDisintegrin and metalloproteinase domain-containing protein 10
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesIncyte Corp
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesIncyte Corp
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A